15-Lipoxygenase-2 expression in human macrophages induces chemokine secretion and T cell migration

Atherosclerosis

Volumn 199, Issue 1, 2008, Pages 34-40

  Danielsson, Kristina Norén ^a   Rydberg, Ellen Knutsen ^a   Ingelsten, Madeleine ^a   Akyürek, Levent M ^a   Jirholt, Pernilla ^a   Ullström, Christina ^a   Forsberg, Gun Britt ^b   Borén, Jan ^a   Wiklund, Olov ^a   Hultén, Lillemor Mattsson ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

15 Lipoxygenase 2; Atherosclerosis; Chemokines; Macrophages; Migration; T cells

Indexed keywords

ARACHIDONATE 15 LIPOXYGENASE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 8; SMALL INTERFERING RNA;

ADENOVIRUS; ARTICLE; ATHEROSCLEROSIS; CELL COUNT; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE TARGETING; HUMAN; HUMAN CELL; HYPOXIA; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ADENOVIRIDAE; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ARACHIDONATE 15-LIPOXYGENASE; ATHEROSCLEROSIS; CD4-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CXCL10; GENE EXPRESSION; HUMANS; INTERLEUKIN-8; MACROPHAGES; RNA, SMALL INTERFERING; TRANSGENES; VASCULITIS;

EID: 45449120515     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.10.027     Document Type: Article

References (36)

1. Glass C.K., and Witztum J.L. Atherosclerosis. The road ahead. Cell 104 4 (2001) 503-516
2. Hansson G.K., and Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6 7 (2006) 508-519
3. Gustafsson M., Flood C., Jirholt P., and Boren J. Retention of atherogenic lipoproteins in atherogenesis. Cell Mol Life Sci 61 1 (2004) 4-9
4. Hansson G.K., Robertson A.K., and Soderberg-Naucler C. Inflammation and atherosclerosis. Annu Rev Pathol Mech Dis 1 (2006) 297-329
5. Bjornheden T., Levin M., Evaldsson M., and Wiklund O. Evidence of hypoxic areas within the arterial wall in vivo. Arterioscler Thromb Vasc Biol 19 4 (1999) 870-876
6. Semenza G.L. Regulation of hypoxia-induced angiogenesis: a chaperone escorts VEGF to the dance. J Clin Invest 108 1 (2001) 39-40
7. Pugh C.W., and Ratcliffe P.J. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9 6 (2003) 677-684
8. Murdoch C., Muthana M., and Lewis C.E. Hypoxia regulates macrophage functions in inflammation. J Immunol 175 10 (2005) 6257-6263
9. Leppanen O., Bjornheden T., Evaldsson M., Boren J., Wiklund O., and Levin M. ATP depletion in macrophages in the core of advanced rabbit atherosclerotic plaques in vivo. Atherosclerosis 188 2 (2006) 323-330
10. Huo Y., Zhao L., Hyman M.C., et al. Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein E-deficient mice. Circulation 110 14 (2004) 2024-2031
11. Rydberg E.K., Krettek A., Ullstrom C., et al. Hypoxia increases LDL oxidation and expression of 15-lipoxygenase-2 in human macrophages. Arterioscler Thromb Vasc Biol 24 11 (2004) 2040-2045
12. Rydberg E.K., Salomonsson L., Hulten L.M., et al. Hypoxia increases 25-hydroxycholesterol-induced interleukin-8 protein secretion in human macrophages. Atherosclerosis 170 2 (2003) 245-252
13. Bostrom P., Magnusson B., Svensson P.A., et al. Hypoxia converts human macrophages into triglyceride-loaded foam cells. Arterioscler Thromb Vasc Biol 24 (2006) 2040-2045
14. Hatley M.E., Srinivasan S., Reilly K.B., Bolick D.T., and Hedrick C.C. Increased production of 12/15 lipoxygenase eicosanoids accelerates monocyte/endothelial interactions in diabetic db/db mice. J Biol Chem 278 28 (2003) 25369-25375
15. Gerszten R.E., Garcia-Zepeda E.A., Lim Y.C., et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398 6729 (1999) 718-723
16. Baccante G., Mincione G., Di Marcantonio M.C., Piccirelli A., Cuccurullo F., and Porreca E. Pravastatin up-regulates transforming growth factor-beta1 in THP-1 human macrophages: effect on scavenger receptor class A expression. Biochem Biophys Res Commun 314 3 (2004) 704-710
17. Morgan E., Varro R., Sepulveda H., et al. Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin Immunol 110 3 (2004) 252-266
18. Brosterhus H., Brings S., Leyendeckers H., et al. Enrichment and detection of live antigen-specific CD4(+) and CD8(+) T cells based on cytokine secretion. Eur J Immunol 29 12 (1999) 4053-4059
19. Sigari F., Lee C., Witztum J.L., and Reaven P.D. Fibroblasts that overexpress 15-lipoxygenase generate bioactive and minimally modified LDL. Arterioscler Thromb Vasc Biol 17 12 (1997) 3639-3645
20. Farber J.M. Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol 61 3 (1997) 246-257
21. Mach F., Sauty A., Iarossi A.S., et al. Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J Clin Invest 104 8 (1999) 1041-1050
22. Heller E.A., Liu E., Tager A.M., et al. Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells. Circulation 113 19 (2006) 2301-2312
23. Yla Herttuala S., Rosenfeld M.E., Parthasarathy S., et al. Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. J Clin Invest 87 4 (1991) 1146-1152
24. Kuhn H., Heydeck D., Hugou I., and Gniwotta C. In vivo action of 15-lipoxygenase in early stages of human atherogenesis. J Clin Invest 99 5 (1997) 888-893
25. Cathcart M.K., and Folcik V.A. Lipoxygenases and atherosclerosis: protection versus pathogenesis. Free Radic Biol Med 28 12 (2000) 1726-1734
26. Li S.L., Dwarakanath R.S., Cai Q., Lanting L., and Natarajan R. Effects of silencing leukocyte-type 12/15-lipoxygenase using short interfering RNAs. J Lipid Res 46 2 (2005) 220-229
27. Spanbroek R., Grabner R., Lotzer K., et al. Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proc Natl Acad Sci USA 100 3 (2003) 1238-1243
28. Kilty I., Logan A., and Vickers P.J. Differential characteristics of human 15-lipoxygenase isozymes and a novel splice variant of 15S-lipoxygenase. Eur J Biochem 266 1 (1999) 83-93
29. Shappell S.B., Gupta R.A., Manning S., et al. 15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells. Cancer Res 61 2 (2001) 497-503
30. Huang J.T., Welch J.S., Ricote M., et al. Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature 400 6742 (1999) 378-382
31. Kuhn H., and O'Donnell V.B. Inflammation and immune regulation by 12/15-lipoxygenases. Prog Lipid Res 45 4 (2006) 334-356
32. Barlic J., Zhang Y., Foley J.F., and Murphy P.M. Oxidized lipid-driven chemokine receptor switch, CCR2 to CX3CR1, mediates adhesion of human macrophages to coronary artery smooth muscle cells through a peroxisome proliferator-activated receptor gamma-dependent pathway. Circulation 114 8 (2006) 807-819
33. Viita H., Sen C.K., Roy S., Siljamaki T., Nikkari T., and Yla-Herttuala S. High expression of human 15-lipoxygenase induces NF-kappaB-mediated expression of vascular cell adhesion molecule 1, intercellular adhesion molecule 1, and T-cell adhesion on human endothelial cells. Antioxid Redox Signal 1 1 (1999) 83-96
34. Bolick D.T., Srinivasan S., Whetzel A., Fuller L.C., and Hedrick C.C. 12/15 lipoxygenase mediates monocyte adhesion to aortic endothelium in apolipoprotein E-deficient mice through activation of RhoA and NF-kappaB. Arterioscler Thromb Vasc Biol 26 6 (2006) 1260-1266
35. Natarajan R., Yang D.C., Lanting L., and Nadler J.L. Key role of P38 mitogen-activated protein kinase and the lipoxygenase pathway in angiotensin II actions in H295R adrenocortical cells. Endocrine 18 3 (2002) 295-301
36. Kunz M., Bloss G., Gillitzer R., et al. Hypoxia/reoxygenation induction of monocyte chemoattractant protein-1 in melanoma cells: involvement of nuclear factor-kappaB, stimulatory protein-1 transcription factors and mitogen-activated protein kinase pathways. Biochem J 366 Pt 1 (2002) 299-306